Profilo
Daniel Richner is currently the Chairman & Chief Executive Officer at M+R Spedag Group AG since 2006.
Prior to this, he worked as an Investment Advisor at HBM Partners AG from 2004 to 2006.
He also held positions as a Director at Pevion Biotech AG, and as a Principal at HBM Healthcare Investments AG, NanoDimension AG, and Cantrade Privatbank AG.
Dr. Richner received his undergraduate, graduate, and doctorate degrees from the University of Basel.
Posizioni attive di Daniel Richner
| Società | Posizione | Inizio |
|---|---|---|
M+R Spedag Group AG
M+R Spedag Group AG Air Freight/CouriersTransportation Provides transportation and logistics services | Amministratore Delegato | 01/01/2006 |
Precedenti posizioni note di Daniel Richner
| Società | Posizione | Fine |
|---|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Investitore di Private Equity | 08/02/2006 |
NanoDimension AG | Corporate Officer/Principal | - |
| HBM HEALTHCARE INVESTMENTS AG | Corporate Officer/Principal | - |
Cantrade Privatbank AG
Cantrade Privatbank AG Regional BanksFinance Operates as a private bank | Corporate Officer/Principal | - |
Pevion Biotech AG
Pevion Biotech AG Pharmaceuticals: MajorHealth Technology Develops efficient and safe vaccines based on proprietary technology | Direttore/Membro del Consiglio | - |
Formazione di Daniel Richner
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Finance |
HBM Healthcare Investments AG
HBM Healthcare Investments AG Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NanoDimension AG | |
M+R Spedag Group AG
M+R Spedag Group AG Air Freight/CouriersTransportation Provides transportation and logistics services | Transportation |
Pevion Biotech AG
Pevion Biotech AG Pharmaceuticals: MajorHealth Technology Develops efficient and safe vaccines based on proprietary technology | Health Technology |
Cantrade Privatbank AG
Cantrade Privatbank AG Regional BanksFinance Operates as a private bank | Finance |
















